RE: Funding?5 Sep 2025 06:04
Early riser, or are you based down under too?
I think the 'hype' is reasonable given the sectors macro & fundamental tail winds. Valuation compared to peers, in the UK & abroad, would also seem to be on the low side. The potential is certainly there & the situation is very different to the usual AIM death spiral finance required to get a mine or biotech developed. MKA are already poking their head into the commercial space, toward the tail end of development.
In terms of cash position, I analysed the full financial statement & cash position is good well into Q1 in a mid case, excluding any major unforeseen expenditures. Additional warrant conversion will help & the SPAC listing could be the key to financial 'freedom' for MKA; IPO's & equivalents have been going hang busters over there & mix in rare earths it could do very nicely.
I'm not sure what kind of money they need to ramp up additional operations or commissioning costs, admitedly, but there looks to be a decent amount of grant, public & private money going around in that space. Others can probably advise better on the potential 'additional' costs you are interested in.
Chart wise I doubt it 'cooled' off because of funding concerns, it was just typical market behaviour with buyer exhaustion & the emergence of a strong seller(s) which has been covered at nauseum in previous posts so no need to re-hash it. Skip to what you need to know now; the trading range for now is 34p - 39p & a purchase close to 34p is a very good a place to enter in the absence of new news or information. 34p is well supported & coincides with 0.618 FIB retracement so its as solid a technical base as your going to get, its a bit thin under there but that should only be considered if we ever close below.